Oncogene - Table of Contents alert Volume 33 Issue 2

If you are unable to see the message below, click here to view.

Advertisement Studying DNA methylation has never been simpler! Diagenode provides a full suite of products dedicated to epigenetics research. Our innovative DNA methylation product line includes: Trusted antibodies - plus the official provider of 5-mc 33D3 antibody Reliable and robust kits for magnetic MeDIP and hMeDIP, bisulfite conversion, and more! Learn more. TABLE OF CONTENTS Volume 33, Issue 2 (January 2014) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement NATURE REVIEWS CANCER & NATURE REVIEWS CLINICAL ONCOLOGY 2014 CALENDAR Download the calendar for FREE As well as plundering the Nature Reviews Cancer image bank for more clinically oriented figures for our 2014 calendar, we have chosen six images and figures from our sister journal, Nature Reviews Clinical Oncology. Our calendar is freely available thanks to support from  OriGene  Review Top Roles of microRNAs during prostatic tumorigenesis and tumor progression Y-X Fang and W-Q Gao Oncogene 2014 33: 135-147; advance online publication, March 4, 2013; 10.1038/onc.2013.54 Abstract | Full Text Original Articles Top Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer J C Montero, A Esparís-Ogando, M F Re-Louhau, S Seoane, M Abad, R Calero, A Ocaña and A Pandiella Oncogene 2014 33: 148-156; advance online publication, December 17, 2012; 10.1038/onc.2012.572 Abstract | Full Text Role of OGR1 in myeloid-derived cells in prostate cancer L Yan, L S Singh, L Zhang and Y Xu Oncogene 2014 33: 157-164; advance online publication, December 10, 2012; 10.1038/onc.2012.566 Abstract | Full Text Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells U Kumari, W Ya Jun, B Huat Bay and A Lyakhovich Oncogene 2014 33: 165-172; advance online publication, January 14, 2013; 10.1038/onc.2012.583 Abstract | Full Text EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors J Wu, D M Patmore, E Jousma, D W Eaves, K Breving, A V Patel, E B Schwartz, J R Fuchs, T P Cripe, A O Stemmer-Rachamimov and N Ratner Oncogene 2014 33: 173-180; advance online publication, January 14, 2013; 10.1038/onc.2012.579 Abstract | Full Text The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle G Ichim, M Mola, M G Finkbeiner, M-P Cros, Z Herceg and H Hernandez-Vargas Oncogene 2014 33: 181-192; advance online publication, January 14, 2013; 10.1038/onc.2012.570 Abstract | Full Text Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility Q Yang, Z Jie, S Ye, Z Li, Z Han, J Wu, C Yang and Y Jiang Oncogene 2014 33: 193-202; advance online publication, December 17, 2012; 10.1038/onc.2012.569 Abstract | Full Text WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells Y Teng, Y Mei, L Hawthorn and J K Cowell Oncogene 2014 33: 203-211; advance online publication, January 14, 2013; 10.1038/onc.2012.565 Abstract | Full Text ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis J Bergholz, Y Zhang, J Wu, L Meng, E M Walsh, A Rai, M Y Sherman and Z-X Jim Xiao Oncogene 2014 33: 212-224; advance online publication, December 17, 2012; 10.1038/onc.2012.564 Abstract | Full Text Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling S M Brouxhon, S Kyrkanides, X Teng, M Athar, S Ghazizadeh, M Simon, M K O'Banion and L Ma Oncogene 2014 33: 225-235; advance online publication, January 14, 2013; 10.1038/onc.2012.563 Abstract | Full Text The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma J R Todd, L L Scurr, T M Becker, R F Kefford and H Rizos Oncogene 2014 33: 236-245; advance online publication, December 17, 2012; 10.1038/onc.2012.562 Abstract | Full Text hCINAP is a novel regulator of ribosomal protein-HDM2-p53 pathway by controlling NEDDylation of ribosomal protein S14 J Zhang, D Bai, X Ma, J Guan and X Zheng Oncogene 2014 33: 246-254; advance online publication, December 17, 2012; 10.1038/onc.2012.560 Abstract | Full Text In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling B Casar, I Rimann, H Kato, S J Shattil, J P Quigley and E I Deryugina Oncogene 2014 33: 255-268; advance online publication, December 3, 2012; 10.1038/onc.2012.547 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.